Maruha Corporation

Maruha Nichiro Seafoods, Inc.

Tadakazu Tamai

Masazumi Nishikawa

Itsuki Murota

Nobuyuki Sato

Kazuyoshi Yoshikai

Nobuaki Yatsuka

Shigeru Moriyama

Kenji Mori

Kenji Sato

Kunio Ogasawara

Takashi Baba

Disclosed is a composition comprising, as an active ingredient, an enzyme digest that is produced by digesting a basic fraction of an animal-derived cartilage extract with an enzyme. Also disclosed is a polypeptide composition comprising, as an active ingredient, at least one polypeptide selected from specific polypeptides including a polypeptide comprising an amino acid sequence depicted in any one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10.

Composition effective to prevent or treat adult disease

The present invention provides an oral preventive or therapeutic agent for skin damage, containing diacylglyceryl ether as an active ingredient represented by the formula (I): wherein Rdenotes Caliphatic hydrocarbon group having a degree of unsaturation of between 0 and 2; Rdenotes Cacyl group having a degree of unsaturation of between 0 and 6; and Rdenotes Cacyl group having a degree of unsaturation of between 0 and 6.

Oral preventive/therapeutic agent for skin damage containing diacylglyceryl ether

The present invention relates to aliphatic compounds of the formula I, or stereoisomers thereof, or their pharmaceutically acceptable salts:wherein A represents an optionally substituted CHCH&#x2014; (wherein n denotes an integer of 4 to 22, and m represents an unsaturation number which is an integer of 0 to 7), l represents an integer of 0 to 10, s represents 0 or 1, provided that when s is 0, p+q=4 or 5, but when s is 1, p+q=3 or 4, and in each case, either p or q is an integer of 1 or more, R represents an alkyl group having 1 to 10 carbon atoms which may be straight-chain or branched-chain, and Rrepresents hydrogen or an alkyl group having 1 to 10 carbon atoms which may be straight-chain or branched-chain, and their use in suppression of platelet aggregation, in suppression of inflammation, and in prevention and treatment of circulatory diseases.

Aliphatic compounds, their synthesis method, and utilization of the same

Sebum production inhibitors containing as an active ingredient a compound of general formula (1) below having a glucuronic acid derivative and a glucosamine derivative in the structure or a pharmacologically acceptable salt thereof

Sebum production inhibitors

Aliphatic compounds, process for their preparation and their usage

{circle around (1)} Compounds of the following general formula (1) having a glucuronic acid derivative and a glucosamine derivative in the structure thereof, pharmacologically acceptable salts and solvates of the compounds, or solvates of the salts, {circle around (2)} a method for producing the compounds {circle around (1)}, {circle around (3)} a pharmaceutical composition containing the compounds {circle around (1)}, {circle around (4)} polymers having at least one of the compounds {circle around (1)} as a side chain structure, {circle around (5)} a coating agent containing the compound {circle around (1)} or the polymer as one of active ingredients, and {circle around (6)} molded products, artificial organs, medical devices, and equipment for cell culture, which have been produced using the polymer {circle around (4)} and/or the coating agent {circle around (5)}.

Growing community of inventors

Ibaraki, Japan

Tadakazu Tamai